Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
93
天
The concealed side of caspases: beyond a killer of cells
作者
Lina Abdelghany; Chanin Sillapachaiyaporn; Boris Zhivotovsky展开收起
作者单位
1. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt; 3. Engelhardt Institute of Molecular Biology, RAS, Moscow, Russia; 4. Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia展开收起
150
天
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors
作者
Karthikeyan Subbarayan; Ahmed Al-Samadi; Helene Schäfer; Chiara Massa; Tuula Salo; Katharina Biehl; Christoforos K. Vaxevanis; Kamatchi Ulagappan; Wafa Wahbi; Matthias Reimers; Felix Drexler; Andres Moreira-Soto; Michael Bachmann; Barbara Seliger展开收起
作者单位
1. Medical Faculty, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; 2. Institute of Dentistry, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Joensuu, Finland; 3. Department of Oral and Maxillofacial Diseases, Clinicum, University of Helsinki, Helsinki, Finland; 4. Institute of Translational Immunology, Brandenburg an der Havel, Germany; 5. Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland; 6. Charité, Institute of Virology, Berlin, Germany; 7. Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; 8. Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; 9. Institute of Translational Medicine, Medical School Theodor Fontane, Brandenburg an der Havel, Germany展开收起
216
天
Heterogeneous neutrophils in lung transplantation and proteolytic CXCL8 activation in COVID-19, influenza and lung transplant patient lungs
作者
Seppe Cambier; Fabio Beretta; Amber Nooyens; Mieke Metzemaekers; Noëmie Pörtner; Janne Kaes; Ana Carolina de Carvalho; Emanuela E. Cortesi; Hanne Beeckmans; Charlotte Hooft; Mieke Gouwy; Sofie Struyf; Rafael E. Marques; Laurens J. Ceulemans; Joost Wauters; Bart M. Vanaudenaerde; Robin Vos; Paul Proost展开收起
作者单位
1. Laboratory of Molecular Immunology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 2. Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium; 3. Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil; 4. Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil; 5. Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium; 6. Medical Intensive Care Unit, Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium; 7. Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 8. Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium展开收起
403
天
Potential compensatory mechanisms preserving cardiac function in myotubular myopathy
作者
Alix Simon; Nadège Diedhiou; David Reiss; Marie Goret; Erwan Grandgirard; Jocelyn Laporte展开收起
作者单位
1. Institute of Genetics and Molecular and Cellular Biology (IGBMC), INSERM U1258, CNRS UMR7104, University of Strasbourg, 1 rue Laurent Fries, Illkirch, France展开收起
164
天
FGF receptor kinase inhibitors exhibit broad antiviral activity by targeting Src family kinases
作者
Debora Stefanova; Dominik Olszewski; Mirco Glitscher; Michael Bauer; Luca Ferrarese; Daria Wüst; Eberhard Hildt; Urs F. Greber; Sabine Werner展开收起
作者单位
1. Institute of Molecular Health Sciences, Department of Biology, ETH Zürich, Zürich, Switzerland; 2. Department of Molecular Life Sciences, University of Zürich, Zurich, Switzerland; 3. Paul-Ehrlich-Institute, Department of Virology, Langen, Germany展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天